Transfus Med Hemother. 2016 Jan;43(1):37-43. doi: 10.1159/000441676. Epub 2015 Nov 04.
Comparison of Two Test Strategies for Clarification of Reactive Results for Anti-HBc in Blood Donors.
Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie
David Juhl, Johannes K-M Knobloch, Siegfried Görg, Holger Hennig
Affiliations
Affiliations
- Institute of Transfusion Medicine, University Hospital of Schleswig-Holstein, Lübeck, Germany.
- Institute of Medical Microbiology and Hygiene, University Hospital of Schleswig-Holstein, Lübeck, Germany.
PMID: 27022321
PMCID: PMC4797462 DOI: 10.1159/000441676
Abstract
OBJECTIVE: Testing for antibodies against hepatitis B core antigen (anti-HBc) was introduced to detect blood donors suffering from occult hepatitis B infection. Confirmation of specification of reactive results in the anti-HBc screening assay is still a challenge for blood donation services.
METHODS: Two different test strategies for confirmation of specification of reactive anti-HBc tests, one performed in our institute and one suggested by the German authority (Paul-Ehrlich-Institut (PEI)), were compared. The first strategy is based on one supplemental anti-HBc test, the other requires two supplemental anti-HBc tests.
RESULTS: 389 samples from 242 donors were considered. Both test strategies yielded concordant results in 117 reactive samples termed 'true-positive' or 'specificity confirmed', in 156 reactive samples termed 'false-positive' or 'specificity not confirmed', and in 99 negative samples. In 17 samples obtained from 11 donors, both test strategies gave discrepant results ('false-positive' but 'specificity confirmed'). In 10 of 11 donors, a real HBV infection was very unlikely, one remained unclear. 30 donors considered 'false-positive' became negative in all anti-HBc tests after follow-up testing and thus eligible for donor re-entry.
CONCLUSIONS: The test strategy suggested by the PEI yielded no additional information but induced an overestimation of HBV infections and unnecessary look-back procedures. Many anti-HBc-reactive donors can be regained after follow-up testing.
Keywords: Anti-HBc; Blood donor; Donor re-entry; HBV DNA; Hepatitis B virus
References
- Transfusion. 2013 Feb;53(2):291-6 - PubMed
- Blood. 2002 Oct 1;100(7):2637-41 - PubMed
- Swiss Med Wkly. 2008 Mar 8;138(9-10):134-41 - PubMed
- Transfusion. 2008 Feb;48(2):286-94 - PubMed
- Eur J Clin Microbiol Infect Dis. 2014 Jan;33(1):69-77 - PubMed
- Transfusion. 2008 Aug;48(8):1602-8 - PubMed
- J Virol Methods. 2008 Dec;154(1-2):206-9 - PubMed
- Transfus Med. 2004 Apr;14(2):97-103 - PubMed
- J Clin Virol. 2011 Aug;51(4):283-4 - PubMed
- J Viral Hepat. 2007 Nov;14 Suppl 1:16-21 - PubMed
- J Hepatol. 2008 Jun;48(6):1022-5 - PubMed
- Transfusion. 2008 Nov;48(11):2315-22 - PubMed
- Transfusion. 2002 Jul;42(7):869-75 - PubMed
- Transfusion. 2013 Jul;53(7):1393-404 - PubMed
- Vox Sang. 2006 Oct;91(3):237-43 - PubMed
- Transfusion. 2007 Oct;47(10):1809-15 - PubMed
- Transfusion. 2011 Jul;51(7):1477-85 - PubMed
- Transfusion. 2003 Jun;43(6):696-704 - PubMed
- Transfusion. 2007 Jul;47(7):1197-205 - PubMed
Publication Types